Curative therapies for cardiovascular disease
Location: United States, California, South San Francisco
Total raised: $300M
Investors 1
| Date | Name | Website |
| 17.05.2025 | ARCH Ventu... | archventur... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 17.06.2026 | IPO | $400M | - |
| 07.02.2025 | Series A | $300M | - |
Mentions in press and media 7
| Date | Title | Description |
| 17.06.2026 | Kardigan raises $400M in IPO to fund three clinical-stage cardiovascular programs | - |
| 15.10.2025 | Kardigan Raises $254M in Series B Funding | Kardigan, a South San Francisco, CA- and Princeton, New Jersey-based heart health company modernizing cardiovascular drug development, closed a $254m Series B financing. Backers included Fidelity Management & Research Company, accounts ... |
| 31.03.2025 | Kardigan Acquires Prolaio | Kardigan, a San Francisco, CA- and Princeton, NJ-based health company modernizing cardiovascular (CV) drug development, acquired Prolaio, a Chicago, IL-based clinical intelligence company advancing cardiology research and care with real-wor... |
| 07.02.2025 | Kardigan Launches with $300M in Series A | SAN FRANCISCO, CA, Kardigan, a heart health company modernizing cardiovascular drug development, launched with a $300 million Series A financing. >> Click here for more funding data on Kardigan >> To export Kardigan funding dat... |
| 13.01.2025 | Kardigan Raises USD300M in Series A Funding | Kardigan, a San Francisco, CA-based heart health company modernizing cardiovascular drug development, raised USD300M in Series A funding. The round was led by Perceptive Advisors, ARCH Venture Partners, and Sequoia Heritage. The company int... |
| 10.01.2025 | Kardigan launches with cozy $300M series A and collection of late-stage cardio assets | A new company is making its debut with a series A sum that’s sure to make hearts race. Launching with $300 million in hand, Kardigan plans to develop parallel treatments to prevent and cure cardiovascular diseases so that they’re no longer ... |
| - | Kardigan | “Kardigan is a heart health company developing drugs designed to make cardiovascular disease curable, preventable, and no longer the leading cause of death.” |